Tel Aviv, August 5: Seedo Corp, an agtech company that is developing the protocols to grow saffron using vertical farming technology has announced that it is expanding its research to include the study of the spice’s well known natural anti-anxiety and antidepressant properties.
Similar to the approach of the indoor cannabis industry, Seedo hopes to be able to enhance the medicinal properties of this unique herb for use in pharmaceutical and nutraceutical applications.
“The timing is right to leverage saffron’s potential medicinal properties and create new applications that could address the recent paradigm shift regarding mental health,” Seedo chief executive David Freidenberg said in a statement.
“Seedo Corp is committed to developing breakthroughs rooted in nature that are effective and safe for athletes and everyday consumers alike.”
Seedo Corp. is an agtech company that focuses on the research, development, and commercialisation of agriculture products that are high in demand but are hindered by the low yields and specifications required by traditional farming.
Seedo’s technology is aimed at offering a responsible and sustainable way to grow crops in a world confronted by environmental challenges and dwindling earth reserves, diminishing water sources and unstable weather conditions.
Mental health has come to the forefront in sports with Simone Biles (pictured above) withdrawing from the Tokyo Olympics and Naomi Osaka opting out of the French Open and Wimbledon.
With mental health entering the cultural conversation, Seedo Corp. hopes saffron will be seen as part of a new nature-based approach to mental health.
“Until recently, the options for treating depression and anxiety were quite limited,” Dr. Nizan Primor, CEO, Naveh Pharma, a company that specializes in creating pharmaceutical and healthcare products with unique active ingredients including saffron said.
“A recent study found that taking 28 mg of saffron daily was just as effective as Fluoxetine, Imipramine, and Citalopram — conventional treatments for depression.”
A study was published in the Journal of Adolescent Psychopharmacology which explicitly found that saffron extract has the same efficacy as Ritalin in improving focus for children with ADHD, suggesting there is a promising future in developing new natural therapies to treat these common ailments.
In another study by the Journal of Psychopharmacology it was discovered that patients who were administered saffron extract for eight weeks saw “a greater improvement in depressive symptoms.”
Seedo Corp successfully harvests saffron using vertical farming technology and hopes to expand the billion dollar saffron market by producing a reliable, consistent and large-scale supply of the spice.
Welcome to dailystraits.com. Please send all interview requests and press releases to editor@dailystraits.com.